In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Therapeutic results of the intra-arterial throbombolysis after full dose intravenous tissue plasminogen activator administration.

    Final Number:
    738

    Authors:
    Dosung Yoo MD PhD

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2014 Annual Meeting

    Introduction: Intravenous (i.v) administration of tissue plasminogen activator (tPA) is accepted as a standard treatment for acute cerebral ischemia, but the clinical outcomes cannot be warranted in patients who are not recanalized after i.v. tPA or who are not indicated for i.v. tPA. In this study, outcomes from the groups of patients using the additional intra-arterial thrombolytic therapy were compared to assess whether i.v. tPA administration was advantageous.

    Methods: Intra-arterial thrombolytic therapy (thrombolytic agents combined with mechanical intervention) was tried for those patients who were not indicated for i.v. tPA and who showed continuous major vessel occlusion after i.v. tPA. Sixty-three patients were divided into two groups, a tPA group (n=29, intra-arterial thrombolysis after i.v. tPA) and non-tPA group (n=34, intra-arterial therombolysis without i.v. tPA). These groups were sub-divided according to matched or mismatched diffusion weighted imaging/perfusion weighted imaging (DWI/PWI) upon magnetic resonance imaging. Treatment results were compared by recanalization rate, clinical outcomes, mortality, and significant intracerebral hemorrhage rate.

    Results: Recanalization rate was 79.3% in the tPA group and 55.9% in the non-tPA group (?2, p<0.05). Subgroup analysis between DWI/PWI mismatched in tPA group and DWI/PWI mismatched in non-tPA group also showed no statistical difference in recanalization rate, favorable clinical outcome, and mortality (?2, p>0.05) but significant intracerebral hemorrhage rate was high in tPA group (?2, p<0.05).

    Conclusions: Additional intra-arterial thrombolytic treatment after full dose i.v. tPA administration might be an acceptable treatment option for the patients with DWI/PWI mismatching.

    Patient Care: To improve the patients outcome, randomized control trial should be performed, which therapy, iv-tPA or IA-Tx is proper for large-artery intracranial occlusion patients. And dynamic images such as CT-angiograogy or MR-angiograohy should incluse as an initial evaluation image instead non-enhance CT.

    Learning Objectives: intraarterial thrombombolysis is need in some patients and clinical result also good.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy